Dimeric procyanidin B2 inhibits constitutively active NF-kB in Hodgkin’s lymphoma cells independently of the presence of IkB mutations

Loading...
Thumbnail Image
Issue Date
2008
Authors
Medical Center Staff
Publisher
Stony Brook Medicine, Stony Brook University